Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis
Internal Medicine · 2024
DOI: 10.2169/internalmedicine.2016-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine, 2024. Verfasst von Satoshi Komiyama und 16 weiteren Autor:innen. Beteiligte Einrichtung: Chemotherapy Department, Yokohama City University Medical Center, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Neuroendocrine Tumors, Carcinoma, Neuroendocrine, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Primary hepatobiliary neuroendocrine neoplasms (NENs) are rare tumors exhibiting several morphological and behavioral characteristics. Considering the lack of relevant data on this topic, we evaluated the clinicopathological features and treatment outcomes of patients with primary hepatobiliary NENs. Methods/Patients We examined 43 consecutive patients treated at the National Cancer Center Hospital with pathological diagnoses of primary hepatobiliary NEN between 1980 and 2016.
Results
Nine patients were diagnosed with neuroendocrine tumor (NET) G1, 9 with NET G2, and 25 with neuroendocrine carcinoma (NEC) based on the World Health Organization 2019 classification. Patients with NEC had primary sites across the hepatobiliary organs, although sites in patients with NET G1 and NET G2 only included the liver and ampulla of Vater. Patients with primary extrahepatic bile duct or ampulla of Vater NENs tended to be diagnosed earlier than patients with primary gallbladder NENs. The median survival times in the NET G1, NET G2, and NEC groups were 167.9, 97.4, and 11.1 months, respectively. A good performance status, absence of distant metastases, and low tumor grade were identified as independent predictors of a favorable prognosis.
Conclusion
The NET-to-NEC ratio and tumor stage distribution at the diagnosis differed depending on the primary site. Patients with G1 and G2 NETs who underwent surgical resection had good prognoses, whereas those with NEC exhibited more advanced disease and poorer prognoses. The performance status, staging classification, and tumor grade are important factors to consider when devising an appropriate treatment strategy and predicting the prognoses of patients with primary hepatobiliary NEN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chemotherapy Department, Yokohama City University Medical Center, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Japan.
- Pathology and Clinical Laboratories, National Cancer Center Hospital, Japan.
- Department of Anatomic Pathology, Tokyo Medical University, Japan.
- Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Japan.
Zitieren
APA
Komiyama, S., Okusaka, T., Maruki, Y., Ohba, A., Nagashio, Y., Kondo, S., Hijioka, S., Morizane, C., Ueno, H., Sukeda, A., Mizui, T., Takamoto, T., Nara, S., Ban, D., Esaki, M., Hiraoka, N., & Shimada, K. (2024). Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis. Internal Medicine. https://doi.org/10.2169/internalmedicine.2016-23
Vancouver
Komiyama S, Okusaka T, Maruki Y, Ohba A, Nagashio Y, Kondo S, et al. Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis. Internal Medicine. 2024. doi:10.2169/internalmedicine.2016-23
BibTeX
@article{Komiyama2024,
author = {Komiyama, Satoshi and Okusaka, Takuji and Maruki, Yuta and Ohba, Akihiro and Nagashio, Yoshikuni and Kondo, Shunsuke and Hijioka, Susumu and Morizane, Chigusa and Ueno, Hideki and Sukeda, Aoi and Mizui, Takahiro and Takamoto, Takeshi and Nara, Satoshi and Ban, Daisuke and Esaki, Minoru and Hiraoka, Nobuyoshi and Shimada, Kazuaki},
title = {Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis},
journal = {Internal Medicine},
year = {2024},
doi = {10.2169/internalmedicine.2016-23}
}
EUVIMED